- Why You And Your Pooch Share Similar Reactions to Life
- How to Gauge Your Personal Risk For a Hernia
- Journalists Talk Medicaid Work Mandate in Georgia and Wage Garnishment Bill in Colorado
- How NYU Langone built 1 of the nation’s fastest-growing GI divisions
- BCBS study: Hospital AI billing tools may be driving up healthcare costs by billions
- The transition gap: How RCA is using recovery housing to prevent relapse
- CMS moves forward with 3rd round of Medicare drug negotiations
- Kroger pharmacies add Zepbound KwikPen
- Nurses navigate AI-generated health information at bedside
- Louisiana senator resumes push to repeal water fluoridation program
- HCA’s highest-earning executives in 2025
- HCA’s highest-earning executives in 2025
- CHS Alabama hospital CEO heads to Florida
- RWJBarnabas New Jersey hospital taps new COO
- Why some health system CEOs are opting out of cross-market expansion
- Stanford Health Care leader to advise agentic AI startup
- Piedmont, Encompass tap CEO for planned Georgia hospital
- Inside Virginia’s 1st ‘tri-accredited’ bariatric surgery center
- The red flags DSOs can’t afford to ignore
- About 82% of public Medicare Advantage rate notice comments tied to ‘dark money’ group: KFF
- 10 federal government, policy updates for dentists to know
- The highest-paid ophthalmologist in the 10 largest Northeastern cities
- Arizona cardiology group pays $4.75M to settle false claims allegations
- Why AI is keeping dental practice owners up at night
- OSF HealthCare uses text outreach after ED visits — and sees 33% engagement
- Medicare spending on ASCs jumps 16% in 1 year: MedPAC
- The uneven competition in physician markets
- ‘Dark Money’ Group Angles for Higher Medicare Advantage Payments
- Judge grants Mississippi hospital pause on Medicaid debt repayment
- Inside the erosion of independence in cardiology
- OIG green-lights ASC cataract supply discount proposal
- Children’s Hospital of Philadelphia anesthesiologist receives lifetime achievement award
- Oceans Behavioral Hospital debuts virtual outpatient program
- UF Health opens 24K-square-foot orthopedic surgical center
- Illinois health association to open $4M dental practice
- 30+ dental industry updates in California, Florida and Texas
- Heartland Dental expands in 4 states
- Crestwood Behavioral Health names program chief
- Dartmouth hospital launches social work department
- Georgia health system launches new digital patient billing system
- 5 DSOs making headlines
- Oceans behavioral health hospital taps CEO
- Amazon launches health AI agent on its website, expands free virtual care to 200M Prime members
- Pediatric dental, orthodontic practice building sold for $4.4M
- San Francisco secures $100M to expand behavioral health treatment to 3 sites
- How nursing backgrounds shaped 2 revenue cycle leaders
- Study Finds 'Forever Chemicals' on California Fruits and Vegetables
- Bad News for Multitaskers: Your Brain Can’t Really Do It
- OSF HealthCare uses digital therapeutics to create a digital path to care
- Former Tenet CFO joins Acadia Healthcare board
- About 3,000 Wayfair Dressers Recalled Over Child Tip-Over Risk
- Microsoft Unveils AI Health Tool That Can Read Your Medical Records
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- The feds will overpay Medicare Advantage plans by $76B this year, MedPAC estimates
- FDA Launches New Adverse Event Look-Up Tool
- FDA Launches New Adverse Event Look-Up Tool
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- Bayer found to have discredited pharma industry after Roche row
- Industry Voices—Fast answers, fragile data: the trust problem in AI-driven healthcare analytics
- Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals
- GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy
- Experts Weigh in on Digital Health Wearables for Neurological Health
- Ultra-Processed Foods Bad For Bone Health, Researchers Say
- AI-Generated Meal Plans For Dieting Teens Could Be Harmful, Study Warns
- Fertility Treatments Aren't Linked To Added Cancer Risk For Women, Study Concludes
- There's One Simple Way Cancer Patients Can Ward Off 'Chemo Brain,' Study Finds
- Younger Stroke Survivors Face Unique Mental Health Hurdles
- 'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success
- Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
- Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
- Doctors Warn of a Deadly Complication From Measles Outbreaks
- FDA scolds CDMO Simtra with warning letter over contamination fumbles
- FDA fires off another manufacturing-related CRL, this one to Hyloris
- Hospital margins take a dive
- Florida woman accused of operating illegal dental clinic out of home
- North Carolina updates mental health bed registry
- Medicare Advantage spending 14% higher than fee for service: Report
- Washington hospital to close pediatric rehab clinic
- New Jersey system partners with health center ahead of ED closure
- What the Health? From KFF Health News: RFK Jr.’s Very Bad Week
- Report on doctor's sexual abuse spurs promises of structural change at Columbia. Survivors say it isn't enough
- Dana-Farber boosts operating margin to 8.4% in Q1
- Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall
- Remarks at the Investor Advisory Committee Meeting
- Pediatric Allergy Specialist: Feed Babies Allergenic Foods Earlier, Not Later
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Doctors Warn Patients to Research Cosmetic Surgery Providers Before Getting Work Done
- Adam’s Lib: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks for the Investor Advisory Committee Meeting
- Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
- AMA: Physicians' use of AI doubled from 2023 to 2026
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- At HIMSS26, Dr. Oz, CMS officials push agentic AI adoption. Are Medicare beneficiaries ready?
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion
- Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli
- FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings
- Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
- Electrodes Partially Restore Movement, Sensation In Spinal Cord Patients
- Genetic Test May Predict Leukemia Relapse Risk
- Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Millions Of Americans Making Financial Sacrifices To Afford Health Care, Survey Finds
- More Concussions Linked To Worse Brain Health Among Recent College Grads
- Years of Specialized Support Essential with Rare Heart Defects
- In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12
- New Medicaid-focused doula provider Malama launches with $9.2M
- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report
- Microsoft unveils Copilot Health as an AI health companion for consumers
- HIMSS26: HHS officials offer updates on interoperability efforts, information blocking enforcement
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Study Links State Taxes to COVID Lockdown Decisions
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- UPDATED: Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Patent expirations push biopharma industry toward a tougher 2026
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- NYU Stern report calls for private equity reforms to safeguard quality of care
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
Interlochen Public Radio interviewed personnel from the Michigan State Police (MSP) Forensic Science Division (FSD) and Harm Reduction Michigan about the changing nature of illegal drugs being confiscated in Michigan:
https://www.michigan.gov/msp/divisions/forensic-science
Purer meth, less pure opioids, more cocaine hit Michigan, testing reveals
By Maxwell Howard of Interlochen Public Radio | February 14, 2026Mexican drug cartels are shipping purer forms of meth into rural Michigan, replacing the drugs that were once made in home labs and full of impurities, police and lab testing data shows.
Meanwhile, opioids have been cut with more impurities that can render overdose treatment ineffective and cocaine use is on the rise, the data shows.
The lab results show rural parts of the state are rife with methamphetamine, cities have more cocaine, and opioids are everywhere in lesser amounts.
While Michigan’s drug overdose deaths have fallen from a high of 3,000 in 2021 to just more than 1,900 in 2024, the most recent state data shows, drug use remains high. Some 269,000 Michiganders 12 and older reported using illicit drugs other than marijuana in 2023 and 2024, the most recent federal data shows.
Local production of meth has grinded to a halt within the last five years, said Elaine Dougherty, lab manager at the Michigan State Police Bridgeport crime lab.
“Now, we get the crystal meth from the drug cartels,” said Doughterty. “It's not made from Sudafed anymore. It's not made in pop bottles anymore. It's literally made in factories in Mexico.”
In Grayling, about 60% of the drugs tested at that crime lab are meth, while Marquette comes in over 80%. Opioids and cocaine each make up roughly 10% to 15% in those labs.
While cocaine is a smaller percentage of the drugs tested across the state, Dougherty said the drug is more popular than it’s been in years, driven in part by increased production in South and Central America.
The number of tests run for cocaine at State Police crime labs statewide has almost doubled within the last three years — from 15% to 28%. That follows global trends showing the number of global cocaine users has grown to 25 million people in 2023, up from 17 million a decade earlier, according to the United Nation’s 2025 World Health Report.
That report says an estimated 3,708 tons of cocaine were manufactured in 2023, increasing by almost 1,000 tons from the year before. The increased supply has increased access and purity of the drug for users.
Opioids, Dougherty said, are the most heavily adulterated drugs on Michigan’s market, with around 20% of synthetic fentanyl samples containing xylazine, a sedative often paired with opioids for its similar effects.
Xylazine does not act on the same opioid receptors pathway, so opioid overdose reversal medication such as Naloxone does not work.
“We were rarely seeing large amounts of xylazine in a sample,” said Doughtery. “I know on the East Coast, they were seeing samples with five times as much xylazine as fentanyl.”
Xylazine levels peaked in Michigan in early 2025, according to MSP lab data, being found in 34% of fentanyl samples. That gradually declined at the end of the year.
Another non-opioid veterinary sedative, medetomidine, has increased from being non-existent in the last year to being found in over 12% of fentanyl samples. That drug behaves much in the same way as xylazine, but is 100 times more potent.
In 2024, three overdoses in Michigan were linked to medetomidine, leading state health officials to raise the alarm.
Damage by xylazine can result in deep skin wounds by restricting blood flow and damaging tissue.
Staff at Traverse City’s Harm Reduction MI office report treating xylazine wounds occasionally — usually with groups and in small timeframes.
“If fentanyl with xylazine makes it to Traverse City, it's likely several people are ingesting it. Especially if you always get your drugs from the same source,” said Dougherty.
One reason for that risk, she said, is that local dealers often don’t know what’s in the drugs.
“The dealers don't know when their stuff has xylazine in it,” said Dougherty. “In an odd way, (dealers) take pride in what they sell. So if they are saying they're selling cocaine, they want those customers to come back. So they want it to be cocaine that they're selling.”
Harm Reduction also tests drugs across the state, but at a different entry point than the State Police. While the state labs test drugs after they are confiscated, Harm Reduction MI tests drugs while they are on the street.
Director Pamela Lynch said most people usually find the nonprofit through word of mouth and come to test their drugs after a bad reaction. Harm Reduction’s testing data often includes more minute data than the state lab, which reports drug mixtures and cocktails.
Lynch’s lab data also reports different cocktails, but also reveals smaller adulterants — substances which appear in drugs incidentally or for little known purposes.
Around two months back, Lynch said, a woman brought in a substance to be tested after her boyfriend had an especially bad reaction and had trouble communicating. The sample later came back with results of PVC plastic.
“A lot of times, people know there's a lot of stuff in there that doesn't belong in there,” said Lynch.
Common adulterants include caffeine, acetaminophen, lidocaine, antidepressants and sugars. Sometimes, the substances are unexpected.
“We even had a sample recently with flower dye,” said Lynch. “The flower dye actually ends up making little spots on their skin.”
Whether knowing what’s in illegal drugs changes behavior — for dealers or people in active addiction — is unclear. But for Lynch, the purpose of her lab is to keep people as healthy as they can until a person is ready for recovery.
“They may think that they have a safe supply. They may trust their dealer,” said Lynch. “They all know they're buying fentanyl. They don't know that they're buying xylazine until they test it.”
This reporting is made possible by the Northern Michigan Journalism Collaborative, led by Bridge Michigan and Interlochen Public Radio, and funded by Press Forward Northern Michigan.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














